Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01508689
Other study ID # 16802
Secondary ID
Status Completed
Phase N/A
First received January 9, 2012
Last updated February 17, 2015
Start date February 2012
Est. completion date December 2014

Study information

Verified date February 2014
Source Texas Woman's University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether eating Kellogg's Nutri-Grain cereal bars will increase calcium intake in healthy adult women.


Description:

The average intake of calcium in women in the United States from the diet (about 800 mg/day) is below the Recommended Dietary Allowance (1000 mg/day for ages 18 to 50 years, 1200 mg/day for age above 50 years), which increases their risk of developing osteoporosis. Consumption of two calcium-fortified cereal bars per day may be a feasible way to increase the dietary intake of calcium. This study will use Kellogg's Nutri-Grain® cereal bars, which provide 200 mg of calcium per bar, or a total of 400 mg/day.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age 18 or older

- Able to speak, read, and understand English

- Able to consume Kellogg's Nutri-Grain® cereal bars

Exclusion Criteria:

- Consumption of calcium supplements or calcium-containing medications

- Regular consumption of 2 Kellogg's Nutri-Grain® cereal bars per month

- Currently pregnant or planning to become pregnant during the course of the study

- Liver disease

- Kidney disease

- Gastrointestinal disease (celiac disease, ulcerative colitis, or Crohn's disease)

- Have a history of bariatric surgery

- Had a major cardiovascular event (stroke or myocardial infarction)

- Undergoing treatment of cancer with the exception of non-melanoma cancer

- Following a weight control diet, a disease specific diet, or a vegan diet

- Have a diagnosed eating disorder

- Allergic to any of the ingredients in the study bar

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Receive Kellogg's Nutri-Grain® cereal bars first
First three weeks of study: consume perceived usual diet; Second three weeks of study: Receive 42 Kellogg's Nutri-Grain® cereal bars per person, consume 2 bars per day; Third three weeks of study: consume perceived usual diet
Receive Kellogg's Nutri-Grain® cereal bars second
First six weeks of study: consume perceived usual diet; Last three weeks of study: Receive 42 Kellogg's Nutri-Grain® cereal bars per person, consume 2 bars per day

Locations

Country Name City State
United States Texas Woman's University Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
Texas Woman's University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dietary calcium intake 1 form of 3-day diet diary per week will be assessed during weeks 2, 6, and 8 of study 9 weeks No
See also
  Status Clinical Trial Phase
Completed NCT01363167 - Identifying Vitamin D Deficiency in Very Low Birth Weight Infant (VLBW) Infants Part 2 N/A
Completed NCT05430932 - Effect Of Laparoscopic Sleeve Gastrectomy on Vitamin D, Parathormone and Calcium Levels N/A
Recruiting NCT04396912 - Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort
Recruiting NCT04823156 - The Effect of Calcium Intake on Calcium and Bone Metabolism During Load Carriage in Women N/A
Not yet recruiting NCT05863949 - Clinical Trial of Vit D and Calcium for Recurrent BPPV N/A
Completed NCT01639222 - Human Pharmacology Trial of Calcium-vitamin D3 Tablet in Healthy Participants Phase 1
Completed NCT04405141 - Uroflowmetry Results and Vitamin D Levels